NCT02378220
- Conditions
- Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +12 more
- Locations
-
- White County Medical Center Home Health Searcy, Arkansas, United States
Clinical trial condition
Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Explore clinical trials studying Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant trial results
NCT01778907
- Conditions
- Behavior, Behavioral Symptoms, Depression, +6 more
- Locations
-
- GGZ WNB Halsteren, North Brabant, Netherlands
- Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
- Reinier van Arkel groep 's-Hertogenbosch, Netherlands
- GGz inGeest Amsterdam, Netherlands
Completed
YouScript IMPACT Registry
NCT02191358
- Conditions
- Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +13 more
- Locations
-
- Dr. Michael Dao Garden Grove, California, United States
- Kaiser Permanente Colorado Denver, Colorado, United States
- Gill Heart Institute Lexington, Kentucky, United States
- IRC Clinics Towson, Maryland, United States
Completed
Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
NCT02428660
- Conditions
- CYP2D6 Polymorphism, Chemically-Induced Disorders, Chronic Disease, +12 more
- Locations
-
- VRx Pharmacy Services Salt Lake City, Utah, United States
Related conditions
- Chemically-Induced Disorders (3)
- Cytochrome P450 CYP2C19 Enzyme Deficiency (3)
- Cytochrome P450 CYP2C9 Enzyme Deficiency (3)
- Cytochrome P450 CYP2D6 Enzyme Deficiency (3)
- Drug Metabolism, Poor, CYP2C19-Related (3)
- Drug Metabolism, Poor, CYP2D6-Related (3)
- Drug-Related Side Effects and Adverse Reactions (3)
- Adverse Drug Events (2)